ライフサイエンスコーパス: catheter ablation

1 sk for recurrent atrial arrhythmia requiring catheter ablation.

2 achycardia (VT) was rendered noninducible by catheter ablation.

3 the phrenic nerve (PN) can hinder successful catheter ablation.

4 uential (n=9) or simultaneous (n=5) unipolar catheter ablation.

5 ssociated with reduced freedom from AF after catheter ablation.

6 r the prediction of rhythm outcomes after AF catheter ablation.

7 c were associated with rhythm outcomes after catheter ablation.

8 ce of spontaneous resolution and the role of catheter ablation.

9 /-10 years; 35% persistent AF) undergoing AF catheter ablation.

10 for the prediction of rhythm outcomes after catheter ablation.

11 (AF) occur in up to 30% within 1 year after catheter ablation.

12 s may influence the long-term outcomes after catheter ablation.

13 osine can unmask dormant AP conduction after catheter ablation.

14 and hemorrhagic events after radiofrequency catheter ablation.

15 has been associated with poor outcomes of AF catheter ablation.

16 ustained VT were ablated with radiofrequency catheter ablation.

17 ignificant subgroup of patients referred for catheter ablation.

18 mple, we identified AF patients treated with catheter ablation.

19 morphism associates with AF recurrence after catheter ablation.

20 TEs in patients undergoing radiofrequency AF catheter ablation.

21 to verify lines of block as an end point for catheter ablation.

22 a structurally normal heart and the role of catheter ablation.

23 ent ECV, 142 underwent PCV, and 79 underwent catheter ablation.

24 phism are predictors for AF recurrence after catheter ablation.

25 astating complication of atrial fibrillation catheter ablation.

26 thy patients with recurrent VT who underwent catheter ablation.

27 atrial tachycardia (AT) after radiofrequency catheter ablation.

28 er ablation strategies, including epicardial catheter ablation.

29 ith DW on periprocedural complications of AF catheter ablation.

30 intervals, and predicted AF recurrence after catheter ablation.

31 ut using any antiarrhythmic agents after the catheter ablation.

32 or persistent AF and potential responders to catheter ablation.

33 ith ischemic cardiomyopathy and ES underwent catheter ablation.

34 g-refractory AF who were planning to undergo catheter ablation.

35 supraventricular tachycardia (SVT) underwent catheter ablation.

36 aps or nontransmural lesions at the sites of catheter ablation.

37 0 mm Hg) treatment before their scheduled AF catheter ablation.

38 reentrant tachycardia and were treated with catheter ablation.

39 nd its association with clinical outcomes of catheter ablation.

40 roperties were prospectively tested to guide catheter ablation.

41 treatment strategy of either radiofrequency catheter ablation (146 patients) or therapy with class I

42 incidence of LVAs in patients undergoing AF catheter ablation, (2) the distribution of LVAs within t

43 At 24 hours after the radiofrequency catheter ablation, 20 (74%) patients had at least 1 new

44 the training set AF terminated in 81% during catheter ablation, 77% were in sinus rhythm after 6 year

45 After catheter ablation, a high baseline HSP27S level could pr

46 During the catheter ablation, a mean number of 10.4+/-7.4 radiofreq

47 After catheter ablation, a programmed ventricular stimulation

48 nts were randomly assigned to receive either catheter ablation (ablation group) with continuation of

49 Catheter ablation allowed for resumption of biventricula

50 for AF termination and long-term success of catheter ablation and compared them with clinical predic

51 to eliminate or modify the triggers through catheter ablation and ultimately an implantable cardiove

52 Twenty-six patients underwent catheter ablation, and 24 patients were rate controlled.

53 time of procedures including cardioversion, catheter ablation, and device implantation.

54 risk of atrial fibrillation recurrence after catheter ablation, and subsequent multimodality imaging

55 commend pulmonary-vein isolation by means of catheter ablation as treatment for drug-refractory parox

56 device who underwent ventricular arrhythmia catheter ablation at 9 tertiary centers were included.

57 ts (age 54+/-11 years, 73% males) undergoing catheter ablation at our institutions were included in t

58 Catheter ablation at these sites, in conjunction with pu

59 Among patients with AF undergoing catheter ablation, atrial tissue fibrosis estimated by d

60 le antiarrhythmic drugs, and 1 to 4 previous catheter ablation attempts (epicardial in 4) had failed.

61 gs and 2+/-1 previous endocardial/epicardial catheter ablation attempts underwent transcoronary ethan

62 ng Persistent Atrial Fibrillation Undergoing Catheter Ablation [BELIEF]; NCT01362738).

63 Clinical Question: Is catheter ablation better than antiarrhythmic drugs for t

64 d lower recurrence rates than radiofrequency catheter ablation, better catheter stability, and lesser

65 improve outcomes in atrial fibrillation (AF) catheter ablation, but the use of this technique remains

66 h more costly inpatient therapies such as AF catheter ablation, but this finding was associated with

67 ting >30 seconds, determined 3 months beyond catheter ablation by a blinded end-point evaluation.

68 Remote-controlled catheter ablation by magnetic navigation in combination

69 goal of this study was to determine whether catheter ablation (CA) for AF could improve LVSD compare

70 Catheter ablation (CA) for atrial fibrillation (AF) has

71 brillation (VLRAF) occuring >12 months after catheter ablation (CA) in apparently "cured" patients co

72 Catheter ablation (CA) is commonly performed for persist

73 Whether catheter ablation (CA) is superior to amiodarone (AMIO)

74 The effects of time to referral for catheter ablation (CA) of scar-related ventricular tachy

75 Catheter ablation (CA) of ventricular tachycardia (VT) i

76 Catheter ablation (CA) of ventricular tachycardia (VT) i

77 ls to examine the safety and the efficacy of catheter ablation (CA) when compared with antiarrhythmic

78 imited ability to predict recurrent VT after catheter ablation (CA).

79 elevated risk for sudden cardiac death, and catheter ablation can be used as adjunctive therapy to t

80 is that approximate the embolic sources from catheter ablation can create hyperintense DWI punctate l

81 al and persistent AF (undergoing their first catheter ablation) conducted between August 2010 and Aug

82 Safe and successful radiofrequency catheter ablation depends on creation of transmural lesi

83 However, catheter ablation did reduce the total number of ICD int

84 ythmias can be cured with techniques such as catheter ablation, drug treatment and prediction of the

85 ot reduce atrial arrhythmia recurrence after catheter ablation for AF but resulted in more hypotensio

86 Catheter ablation for AF is a promising therapy, whose s

87 with recurrence of atrial arrhythmias after catheter ablation for AF.

88 lation (ERAF) is common after radiofrequency catheter ablation for AF.

89 rhagic events are worrisome complications of catheter ablation for atrial fibrillation (AF).

90 neficiaries >/=65 years of age who underwent catheter ablation for atrial fibrillation between July 1

91 Radiofrequency catheter ablation for atrial fibrillation has become an

92 Major complications after catheter ablation for atrial fibrillation were associate

93 blished success rates such as radiofrequency catheter ablation for atrial fibrillation.

94 A total of 15 423 patients underwent catheter ablation for atrial fibrillation.

95 between the study arms significantly favored catheter ablation for both the primary end point and all

96 Eighty-seven patients underwent catheter ablation for drug-refractory VT.

97 9 men; age, 52.8+/-15.5 years) who underwent catheter ablation for focal VA (11 ventricular tachycard

98 aborative database of patients who underwent catheter ablation for infarct-related VT.

99 This study describes the 5-year efficacy of catheter ablation for long-standing persistent atrial fi

100 Long-term outcome data after catheter ablation for LS-AF are limited.

101 his study was to describe the outcomes after catheter ablation for nonischemic VT in a large cohort a

102 Patients undergoing catheter ablation for papillary muscle, fascicular, or m

103 validates the use of a blanking period after catheter ablation for paroxysmal atrial fibrillation but

104 a show that remote IPC before radiofrequency catheter ablation for paroxysmal atrial fibrillation sig

105 study aimed to determine 5-year efficacy of catheter ablation for persistent atrial fibrillation (AF

106 The success rate of catheter ablation for persistent atrial fibrillation (AF

107 ineteen patients underwent LA mapping before catheter ablation for persistent atrial fibrillation.

108 pendent predictors of VT-free survival after catheter ablation for post-myocardial infarction ventric

109 Two patients underwent catheter ablation for recurrent AF or left atrial flutte

110 an age 48 +/- 16 years; 83% male) undergoing catheter ablation for scar-related right ventricular VT,

111 One hundred three patients undergoing catheter ablation for symptomatic AF (66% paroxysmal AF;

112 d brain lesions are common after left atrial catheter ablation for symptomatic atrial fibrillation.

113 Catheter ablation for ventricular arrhythmia (VA) near t

114 Of the 891 consecutive patients undergoing catheter ablation for ventricular arrhythmias, 226 patie

115 Catheter ablation for ventricular tachycardia (VT) from

116 Catheter ablation for ventricular tachycardia and premat

117 lity constitute significant end points after catheter ablation for VT.

118 cular outflow tract (LVOT) sometimes require catheter ablation from both the endocardial and epicardi

119 cular outflow tract (LVOT) sometimes require catheter ablation from the endocardial and epicardial si

120 ial and simultaneous unipolar radiofrequency catheter ablation from the endocardial and epicardial si

121 Patients treated with catheter ablation had a significantly lower rate of stro

122 Catheter ablation has become an established treatment mo

123 Radiofrequency catheter ablation has become the treatment strategy of c

124 atrial fibrillation despite medical therapy, catheter ablation has been shown to substantially reduce

125 Formation of microemboli during catheter ablation has been suggested as a cause for asym

126 Although catheter ablation has been used to target the critical i

127 fibrillation (AF), enlarged atria, or failed catheter ablation have advanced AF and may require more

128 as 57 were assigned ICD implantation without catheter ablation (ICD-only group: 66+/-8 years; 46 men)

129 Catheter ablation improves cardiac function in patients

130 9%, including spontaneous resolution without catheter ablation in 34%.

131 We analyzed results of radiofrequency catheter ablation in a large cohort of patients with CHD

132 data on outcomes following cardioversion or catheter ablation in AF patients treated with factor Xa

133 mic drug therapy, electric cardioversion, or catheter ablation in comparison with men.

134 art disease and discuss the evolving role of catheter ablation in decreasing ventricular arrhythmia r

135 nts recurrent atrial fibrillation (AF) after catheter ablation in patients with AF and a high symptom

136 gate the outcomes following cardioversion or catheter ablation in patients with atrial fibrillation (

137 ct of metabolic syndrome (MS) on outcomes of catheter ablation in patients with atrial fibrillation (

138 was to investigate the long-term outcomes of catheter ablation in patients with nonparoxysmal AF.

139 for AF termination and long-term success of catheter ablation in patients with persistent AF is at l

140 factors that predict recurrence of VT after catheter ablation in patients with prior infarctions are

141 contribute to more widespread utilization of catheter ablation in the future.

142 /- 9 years), who underwent electrogram-based catheter ablation in the left atrium and coronary sinus

143 analyses and were subsequently eradicated by catheter ablation in these patients.

144 nital heart disease (CHD) and the outcome of catheter ablation in this population have not been studi

145 ne the ventricular substrate and outcomes of catheter ablation in this population.

146 Catheter ablation is a more effective and increasingly u

147 Catheter ablation is an effective nonpharmacological alt

148 Catheter ablation is an important therapeutic option in

149 Catheter ablation is an increasingly utilized treatment

150 In these patients, catheter ablation is considered for symptom management o

151 Catheter ablation is effective in restoring sinus rhythm

152 Catheter ablation is effective in terminating VT storm a

153 This study demonstrates that the outcome of catheter ablation is favorable in patients with simple C

154 Intramyocardial infusion-needle catheter ablation is feasible and permits control of som

155 criterion for lateral conduction block after catheter ablation is identification of a late-activated

156 Catheter ablation is important for treatment of paroxysm

157 Catheter ablation is increasingly used in patients for w

158 l and the population we tested, prophylactic catheter ablation is not yet ready for widespread clinic

159 current VT due to nonischemic heart disease, catheter ablation is often useful, although the outcome

160 ve control of FAT with medications; however, catheter ablation is used for most patients.

161 Radiofrequency catheter ablation is used to treat recurrent ventricular

162 In the meantime, catheter ablation is widely used for the treatment of pe

163 roxysmal AF patients who received a stepwise catheter ablation (isolation of the pulmonary veins plus

164 Its use during radiofrequency catheter ablation may allow the operator to assess the d

165 In these individuals, catheter ablation may be used as adjunctive therapy to t

166 as used to identify AF patients treated with catheter ablation (n=3194) or antiarrhythmic drugs witho

167 amiodarone [n=103] or sotalol [n=78]) and AF catheter ablation (n=49) or the Maze procedure at surgic

168 of asymptomatic patients who did not undergo catheter ablation (n=883, with follow-up ranging from 8

169 ctroporation seems to be a safe modality for catheter ablation near the esophagus.

170 ies that a CW strategy during radiofrequency catheter ablation of AF reduces the risk of thromboembol

171 Web databases for studies on radiofrequency catheter ablation of AF under CW versus DW with periproc

172 rst randomized study showing that performing catheter ablation of AF without warfarin discontinuation

173 ted with worse outcomes after radiofrequency catheter ablation of AF, but LA low voltage areas were m

174 risk alleles predict recurrence of AF after catheter ablation of AF.

175 rigated radiofrequency ablation (RFA) during catheter ablation of AF.

176 AF sources and are not suitable targets for catheter ablation of AF.

177 describe a novel individualized approach for catheter ablation of atrial fibrillation (AF) based on l

178 Catheter ablation of atrial fibrillation (AF) became an

179 scores for thromboembolic events (TEs) after catheter ablation of atrial fibrillation (AF).

180 Catheter ablation of atrial fibrillation (AFCA) is an es

181 tudies and clinical trials of radiofrequency catheter ablation of atrial fibrillation between 1990 an

182 To readers of the literature, radiofrequency catheter ablation of atrial fibrillation could be percei

183 Catheter ablation of atrial fibrillation has a low incid

184 Catheter ablation of atrial fibrillation has reached sat

185 Catheter ablation of atrial fibrillation is associated w

186 However, catheter ablation of atrial fibrillation should be consi

187 ncidence of periprocedural complications for catheter ablation of atrial fibrillation was 2.9% (95% c

188 usion weighted MRI (DWI) scans shortly after catheter ablation of atrial fibrillation, but the pathog

189 Among studies of radiofrequency catheter ablation of atrial fibrillation, high success r

190 ers have demonstrated improved outcome after catheter ablation of atrial fibrillation.

191 agopericardial fistulas after radiofrequency catheter ablation of atrial fibrillation.

192 eighted MRI lesions have been observed after catheter ablation of atrial fibrillation.

193 ) of atrial tachyarrhythmia are common after catheter ablation of atrial fibrillation.

194 dage (LAA) isolation (LAAI) may occur during catheter ablation of atrial tachyarrhythmias.

195 Cumulatively, catheter ablation of AVNRT continued to be effective in

196 Catheter ablation of electrical storms (ES) for ventricu

197 n anatomic obstacles preclude radiofrequency catheter ablation of idiopathic ventricular arrhythmias

198 9% male; mean age, 58+/-11 years) undergoing catheter ablation of paroxysmal (59%) or persistent (41%

199 11 years; 17 male) undergoing radiofrequency catheter ablation of paroxysmal atrial fibrillation to r

200 isolation is the most prevalent approach for catheter ablation of paroxysmal atrial fibrillation.

201 (The Randomized Catheter Ablation of Persist End Atrial Fibrillation Stu

202 tic factors for arrhythmia recurrences after catheter ablation of persistent AF using the stepwise ap

203 Catheter ablation of persistent AF using the stepwise ap

204 sequent ATs for arrhythmia recurrences after catheter ablation of persistent AF.

205 novations have been introduced to facilitate catheter ablation of post-myocardial infarction ventricu

206 (AHD) in patients undergoing radiofrequency catheter ablation of scar-related ventricular tachycardi

207 in 11% of patients undergoing radiofrequency catheter ablation of scar-related VT and is associated w

208 nsecutive patients undergoing radiofrequency catheter ablation of scar-related VT.

209 Catheter ablation of subsequent ATs increases freedom fr

210 the multicenter experience with percutaneous catheter ablation of sustained monomorphic ventricular t

211 The catheter ablation of the parietal band VAs was always ch

212 Catheter ablation of the slow conducting pathway (SP) is

213 g extracorporeal membrane oxygenation during catheter ablation of unstable ventricular tachycardia (V

214 study compares outcomes and complications of catheter ablation of VA from the papillary muscles of th

215 Prior studies evaluating the efficacy of catheter ablation of ventricular tachycardia (VT) among

216 Catheter ablation of ventricular tachycardia (VT) in arr

217 Data on outcomes after catheter ablation of ventricular tachycardia (VT) in pat

218 Catheter ablation of ventricular tachycardia (VT) is bei

219 Catheter ablation of ventricular tachycardia (VT) is eff

220 Catheter ablation of ventricular tachycardia (VT) is sti

221 Epicardial radiofrequency catheter ablation of ventricular tachycardia remains cha

222 Catheter ablation of VT among LVAD recipients is feasibl

223 Catheter ablation of VT associated with LMNA cardiomyopa

224 l heart disease who underwent radiofrequency catheter ablation of VT in 2 centers were included.

225 ely to compare outcomes after radiofrequency catheter ablation of VT in patients with NIDCM compared

226 Catheter ablation of VT is currently recommended only as

227 med to investigate the effects of successful catheter ablation of VT on cardiac mortality in patients

228 We hypothesized that in patients undergoing catheter ablation of VT, scar substrates with multiple e

229 ion is necessary for improved outcomes after catheter ablation of VT.

230 promise for identifying important sites for catheter ablation of VT.

231 ify patients who will have recurrences after catheter ablations of nonparoxysmal AF.

232 e investigated the effect of restoring SR by catheter ablation on left ventricular (LV) function and

233 eate deep lesions and is a safe modality for catheter ablation on or near coronary arteries.

234 We investigated the impact of catheter ablation on ventricular tachycardia (VT) recurr

235 LV ejection fraction <50% were randomized to catheter ablation or medical rate control.

236 , and persistent AF were assigned to undergo catheter ablation or rate control.

237 ith electrophysiological characteristics and catheter ablation outcomes were investigated.

238 oke reduction benefit of rhythm control with catheter ablation over a rate control strategy.

239 studies have demonstrated the superiority of catheter ablation over pharmacological therapy for maint

240 y vein isolation versus single tip wide area catheter ablation-paroxysmal atrial fibrillation is the

241 to-treat analysis, 54 were randomly assigned catheter ablation plus ICD implantation (ablation group:

242 Within a dedicated VT unit, catheter ablation prevents long-term VT recurrences, whi

243 Achieving a combined catheter ablation procedural end point of VT noninducibi

244 etween the first diagnosis of PersAF and the catheter ablation procedure had a strong association wit

245 Management requires catheter ablation procedures for effective suppression o

246 success rates are still major limitations of catheter ablation procedures for the treatment of atrial

247 Catheter ablation procedures have evolved over the last

248 because of prior infarction referred for 600 catheter ablation procedures were reviewed.

249 arrhythmia management devices and performing catheter ablation procedures with little or no risk from

250 43.2%) patients after 18 (43.9%) left atrial catheter ablation procedures.

251 n 62% of patients) undergoing 74 unstable VT catheter ablation procedures.

252 Radiofrequency catheter ablation reduced implantable cardioverter-defib

253 fibrillation undergoing PVI from the Swedish Catheter Ablation Register were included, with informati

254 patient-years) with 81% off anticoagulation, catheter ablation reinterventions in 13 patients for atr

255 , critical to their relevance as targets for catheter ablation, requires simultaneous global mapping

256 Catheter ablation resulted in complete procedural succes

257 gulation with warfarin during radiofrequency catheter ablation (RFA) of atrial fibrillation is associ

258 was to assess the efficacy of radiofrequency catheter ablation (RFA) of VT in ARVD/C, with particular

259 study examined the effect of radiofrequency catheter ablation (RFA) on reducing morbidity and mortal

260 gical testing with or without radiofrequency catheter ablation (RFA).

261 Radiofrequency catheter ablation (RFCA) of idiopathic ventricular arrhy

262 Radiofrequency catheter ablation (RFCA) of ventricular tachycardia (VT)

263 ss the efficacy and safety of radiofrequency catheter ablation (RFCA) of VT in patients with myocardi

264 Maintenance of sinus rhythm with drugs or catheter ablation should be considered based on the indi

265 ses that can be transected by radiofrequency catheter ablation similar to isthmus block for atrial fl

266 Virtual EPS may be helpful to plan catheter ablation strategies or to identify patients who

267 We sought to compare the effect of a catheter ablation strategy with that of a medical rate c

268 Studies of patients presenting for catheter ablation suggest that premature ventricular con

269 When a standard catheter ablation targeting the best electrophysiologica

270 tiarrhythmic drugs and standard percutaneous catheter ablation techniques portends a poor prognosis.

271 tiarrhythmic drugs and standard percutaneous catheter ablation techniques.

272 Specifically, the advances in catheter ablation technology and strategies have not tra

273 ropriate ICD shock among patients undergoing catheter ablation than among those receiving an escalati

274 wall enhancement) predicts poor response to catheter ablation therapy for AF.

275 Although catheter ablation therapy for atrial fibrillation (AF) i

276 Catheter ablation therapy, commonly used in the treatmen

277 Ts that have been refractory to conventional catheter ablation therapy, warranting further study.

278 ofrequency instruments, required endocardial catheter ablation to complete the linear ablation lesion

279 Catheter ablation to restore and maintain sinus rhythm i

280 The initial 57 patients (group A) underwent catheter ablation using a novel superolateral MIL design

281 m safety and effectiveness of radiofrequency catheter ablation using an open-irrigated catheter.

282 atients with persistent AF underwent de novo catheter ablation using the stepwise approach (2007-2009

283 (Catheter Ablation Versus Medical Rate Control in Atrial

284 (A Randomised Trial to Assess Catheter Ablation Versus Rate Control in the Management

285 Catheter ablation was done without MGT because the ablat

286 Bottom Line: Radiofrequency catheter ablation was found to be superior to antiarrhyt

287 Catheter ablation was guided by activation/entrainment m

288 Catheter ablation was performed in 98 consecutive patien

289 Catheter ablation was performed targeting LAVA with an i

290 Catheter ablation was successful in 10 patients, and VAs

291 Catheter ablation was successful in 80% of patients.

292 recurrent ventricular tachycardia undergoing catheter ablation, we retrospectively analyzed electrogr

293 l tachyarrhythmias undergoing radiofrequency catheter ablation were classified according to complexit

294 lar (LV) ejection fraction and who underwent catheter ablation were studied.

295 We studied 55 patients with AF who underwent catheter ablation while in sinus rhythm; 20 patients wer

296 Although catheter ablation will benefit patients with predominant

297 re are limited data comparing radiofrequency catheter ablation with antiarrhythmic drug therapy as fi

298 This study sought to compare catheter ablation with rate control for persistent atria

299 Catheter ablation with substrate modification is effecti

300 lesion size after epicardial electroporation catheter ablation with various energy levels after subxi